Article thumbnail

Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: Up-dated baseline data from randomized and multi-site clinical trials

By Didier Ménard, Arsène Ratsimbasoa, Milijaona Randrianarivelojosia, Léon-Paul Rabarijaona, Lucie Raharimalala, Olivier Domarle, Laurence Randrianasolo, Arthur Randriamanantena, Martial Jahevitra, Valérie Andriantsoanirina, Marie-Ange Rason, Rogelin Raherinjafy, Emma Rakotomalala, Luciano Tuseo and Andrianirina Raveloson
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2311320
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2004). Antimalarial drug resistance.
  2. (2002). Ariey F: Malaria study in the cyclone risk zone: entomological , diagnostic and therapeutic approach in the southeastern region of Madagascar. Arch Inst Pasteur Madagascar
  3. (2002). Ariey F: National Network study to perpetuate the surveillance of Plasmodium falciparum sensitivity to antimalarials in Madagascar. Arch Inst Pasteur Madagascar
  4. (1995). Blanchy S: Particularities and stratification of malaria in Madagascar. Sante
  5. (1984). Coulanges P: 4-Aminoquinoline-sensitivity of Plasmodium falciparum
  6. (1984). Coulanges P: 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast. Arch Inst Pasteur Madagascar
  7. (1984). Coulanges P: 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. II. Study in two regions of the east coast. Arch Inst Pasteur Madagascar
  8. (2002). CV: Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
  9. (2003). Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug-efficacy study: Comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg
  10. la Santé du Planning Familial et de la Protection Sociale : Plan Stratégique de Lutte Contre Le Paludisme. Du contrôle vers l’élimination du paludisme à Madagascar : Extension et consolidation des zones indemnes du paludisme (2007-2012). 2007:p 54.
  11. (2005). la Santé et du Planning Familial: Politique National de Lutte contre le Paludisme.
  12. (2002). Mauclere P: Mapping of a Plasmodium falciparum pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar.
  13. (2004). Monitoring susceptibility to sulfadoxine-pyrimethamine among cases of uncomplicated, Plasmodium falciparum malaria in Saharevo, Madagascar. Ann Trop Med Parasitol
  14. (2003). Organization: Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria.
  15. (2004). Parzy D: Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in
  16. (2007). PB: The anatomy of a malaria disaster: drug policy choice and mortality in African children. Lancet Infect Dis
  17. (2007). Rabarijaona LP: Drug-Resistant Malaria Parasites Introduced into Madagascar from Comoros Islands. Emerg Infect Dis
  18. (2003). Randrianarivelojosia M: Assessment of sulfadoxine-pyrimethamine (Fansidar, Paludar) efficacy in patients with uncomplicated malaria in Madagascar: preliminary study to propose a simplified study protocol. Arch Inst Pasteur Madagascar
  19. (2007). Randrianarivelojosia M: Therapeutic efficacy of amodiaquine against uncomplicated malaria in Madagascar. Sante
  20. (2003). Snow RW: Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis
  21. (2007). Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros. Bull Soc Pathol Exot
  22. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature
  23. (2001). The public health impact of chloroquine resistance in Africa.
  24. (2006). Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children.
  25. (2004). White NJ: In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother
  26. (2004). WM: WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet